Evidence map›Paper›PMID 39243289›Full record

Trial reportInternational orthopaedics2024

Long-term follow-up of bone density changes in total hip arthroplasty: comparative analysis from a randomized controlled trial of a porous titanium construct shell vs. a porous coated shell.

Michael Axenhus, Mats Salemyr, Sebastian Mukka, Martin Magnéli, Olof Sköldenberg

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in International orthopaedics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael AxenhusDivision of Orthopaedics, Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Entrévägen 2, 182 88, Danderyd, Stockholm, Sweden. michael.axenhus@ki.se.ORCID 0000-0002-2476-4465
Mats SalemyrDivision of Orthopaedics, Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Entrévägen 2, 182 88, Danderyd, Stockholm, Sweden.
Sebastian MukkaDepartment of Diagnostics and Intervention (Orthopaedics), Umeå University, Umeå, Sweden.
Martin MagnéliDivision of Orthopaedics, Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Entrévägen 2, 182 88, Danderyd, Stockholm, Sweden.
Olof SköldenbergDivision of Orthopaedics, Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Entrévägen 2, 182 88, Danderyd, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePeriacetabular bone loss poses a considerable challenge in the longevity and stability of acetabular implants used in total hip arthroplasty (THA). Innovations in implant design, specifically the introduction of three-dimensional (3D) porous titanium constructs, might reduce bone resorption. The purpose of this study was to build upon our previous randomized controlled trial, which found no change in periacetabular bone loss between a 3D porous none-hydroxyapatite coated titanium cup and a standard porous hydroxyapatite coated cup over a two year follow-up period by extending the follow-up duration to ten years post-surgery.

methodsThis was a single-centre, long-term follow-up study conducted over a ten year period in patients who had previously participated in a randomized controlled trial comparing a 3D porous titanium construct shell (PTC group) with a standard porous hydroxyapatite coated titanium shell (PC-group). The primary outcome measured was the change in bone mineral density (BMD) within four specific periacetabular zones, alongside overall bone loss, which was assessed through BMD in the lumbar spine at two, six and ten years postoperatively. Secondary outcomes included clinical outcome measures.

resultsIn total, 18 in the PTC and 20 in the PC group were analysed for the primary endpoint up to ten years. The mean bone mineral density in zones 1-4 was 3.7% higher in the PTC group than in the PC group at six years postoperatively and 12.0% higher at ten years. Clinical outcomes, and the frequency of adverse events did not differ between the groups.

conclusionsThe PTC group displayed superior long-term bone preservation compared to the PC group while maintaining similar clinical outcomes up to ten years postoperatively. Although with a small sample size, our findings suggest that porous titanium cups have the potential to minimize BMD loss around the cup which could contribute to improving THA outcomes and implant durability.

Indexed as

Arthroplasty, Replacement, HipBone DensityHip ProsthesisProsthesis DesignTitaniumAcetabulumAgedBone ResorptionCoated Materials, BiocompatibleDurapatiteFemaleFollow-Up StudiesHumansMaleMiddle AgedPorosityCoated Materials, BiocompatibleDurapatiteTitaniumBone mineral densityImplant material selectionLong-term follow-upPeriacetabular bone lossPorous titanium cupTHA

Identifiers

PMID39243289
PMCPMC11490515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.